Coppell Advisory Solutions’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Coppell Advisory Solutions's BBIO Position: Q3 2026 in Review
Coppell Advisory Solutions opened a new position in BridgeBio Pharma (BBIO) in Q3 2026: 4,045 shares worth $267K. The stake represents 0.03% of the portfolio and ranks #289 among its holdings.
469 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Coppell Advisory Solutions held 4,045 shares of BridgeBio Pharma worth $267K as of Q3 2026.
- BridgeBio Pharma was a new Coppell Advisory Solutions position in Q3 2026.
- BridgeBio Pharma made up 0.03% of Coppell Advisory Solutions's portfolio in Q3 2026, its #289 holding.
- 469 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Coppell Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.